Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.46 AUD -2.13% Market Closed
Market Cap: 99.4m AUD
Have any thoughts about
Somnomed Ltd?
Write Note

Somnomed Ltd
Investor Relations

SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.

Show more

Earnings Calls

No Earnings Calls Available

Management

Ms. Karen Borg B.A.
Co-CEO & Executive Director
No Bio Available
Mr. Mark Harding
Vice President of Global Marketing
No Bio Available
Mr. Matthew Conlon
Executive VP of Sales & Marketing - North America
No Bio Available
Mr. Marco Van Kleef
Vice President of Marketing & Sales - Europe
No Bio Available
Ms. Ye-Fei Guo
Chief Financial Officer
No Bio Available
Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., SF FIN
Company Secretary
No Bio Available
Mr. Christopher Bedford
Vice President of Global Production and Product Development
No Bio Available

Contacts

Address
NEW SOUTH WALES
Sydney
L 3 20 Clarke St, Crows Nest
Contacts
+61294670400.0
somnomed.com